Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

To establish the glycemic threshold for onset of neuroglycopenia (impaired cognitive function, measured by the latency of the P300 wave), activation of hormonal counterregulation and hypoglycemic symptoms, 12 normal subjects were studied either under conditions of insulin-induced, glucose-controlled plasma glucose decrements, or during maintenance of euglycemia. A decrement in plasma glucose concentration from 88 +/- 3 to 80 +/- 1 mg/dl for 150 min did not result in changes in the latency of the P300 wave nor in an activation of counterregulatory hormonal response. In contrast, a greater decrement in plasma glucose concentration from 87 +/- 3 to 72 +/- 1 mg/dl for 120 min caused an increase in the latency of the P300 wave (from 301 +/- 12 to 348 +/- 20 ms, P less than 0.01), a subsequent increase in all counterregulatory hormones but no hypoglycemic symptoms. Finally, when plasma glucose concentration was decreased in a stepwise manner from 88 +/- 2 to 50 +/- 1 mg/dl within 75 min, the increase in the latency of the P300 wave was correlated with the corresponding plasma glucose concentration (r = -0.76, P less than 0.001). The glycemic threshold for hypoglycemic symptoms was 49 +/- 2 mg/dl. Thus, in normal man the glycemic threshold for neuroglycopenia (72 +/- 1 mg/dl) is greater than currently thought; the hormonal counterregulation follows the onset of neuroglycopenia; the hypoglycemic symptoms are a late indicator of advanced neuroglycopenia.

[1]  B Stigsby,et al.  Glycaemic threshold for changes in electroencephalograms during hypoglycaemia in patients with insulin dependent diabetes , 1988, British medical journal.

[2]  W. Tamborlane,et al.  Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. , 1987, The New England journal of medicine.

[3]  P. Cryer,et al.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. , 1987, The Journal of clinical investigation.

[4]  S. Genuth,et al.  Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group , 1987, Diabetes Care.

[5]  A. McCall,et al.  Chronic hypoglycemia increases brain glucose transport. , 1986, The American journal of physiology.

[6]  U. Smith,et al.  Altered Recognition of Hypoglycaemic Symptoms in Type I Diabetes during Intensified Control with Continuous Subcutaneous Insulin Infusion , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[7]  P. Brunetti,et al.  Comparison of Glucose Counterregulation During Short-Term and Prolonged Hypoglycemia in Normal Humans , 1986, Diabetes.

[8]  C. Binder,et al.  Cognitive function during hypoglycaemia in type I diabetes mellitus. , 1986, British medical journal.

[9]  A. Starr,et al.  Cognitive evoked potentials (P300) in early Huntington's disease. , 1985, Archives of neurology.

[10]  R. DeFronzo,et al.  Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. , 1985, Annals of internal medicine.

[11]  P. Cryer,et al.  Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. , 1985, The New England journal of medicine.

[12]  K. Polonsky,et al.  Variable Deterioration in Cortical Function During Insulin-induced Hypoglycemia , 1985, Diabetes.

[13]  W. Kerner,et al.  Incidence of Hypoglycemic Episodes in Diabetic Patients Under Continuous Subcutaneous Insulin Infusion and Intensified Conventional Insulin Treatment: Assessment by Means of Semiambulatory 24-hour Continuous Blood Glucose Monitoring , 1985, Diabetes Care.

[14]  S. Faux,et al.  Long‐latency event‐related potentials in the evaluation of cognitive function in children , 1985, Neurology.

[15]  C. Holmes,et al.  Verbal Fluency and Naming Performance in Type I Diabetes at Different Blood Glucose Concentrations , 1984, Diabetes Care.

[16]  P. Cryer,et al.  Glucose counterregulation during prolonged hypoglycemia in normal humans. , 1984, The American journal of physiology.

[17]  R. Unger,et al.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. , 1984, The Journal of clinical investigation.

[18]  A. Starr,et al.  P300 latency correlates with digit span. , 1983, Psychophysiology.

[19]  W. Pardridge Brain metabolism: a perspective from the blood-brain barrier. , 1983, Physiological reviews.

[20]  K. Polonsky,et al.  Lack of Glucagon Response to Hypoglycemia in Type I Diabetics After Long-Term Optimal Therapy with a Continuous Subcutaneous Insulin Infusion Pump , 1983, Diabetes.

[21]  L. Kaufman,et al.  The hippocampal formation as a source of the slow endogenous potentials. , 1983, Electroencephalography and clinical neurophysiology.

[22]  C. Holmes,et al.  A Survey of Cognitive Functioning at Different Glucose Levels in Diabetic Persons , 1983, Diabetes Care.

[23]  A. Gjedde,et al.  Blood-brain glucose transfer: repression in chronic hyperglycemia. , 1981, Science.

[24]  G. Reaven,et al.  Enhanced Glucose Utilization During Prolonged Glucose Clamp Studies , 1981, Diabetes.

[25]  E. B. French,et al.  Hormonal and substrate responses during recovery from hypoglycaemia in man during beta1‐selective and non‐selective beta‐adrenergic blockade , 1981, European journal of clinical investigation.

[26]  W. Pritchard Psychophysiology of P300. , 1981, Psychological bulletin.

[27]  J. Rohrbaugh,et al.  Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. , 1980, Science.

[28]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[29]  K. Squires,et al.  Long latency event-related components of the auditory evoked potential in dementia. , 1978, Brain : a journal of neurology.

[30]  K. Squires,et al.  Age-related variations in evoked potentials to auditory stimuli in normal human subjects. , 1978, Electroencephalography and clinical neurophysiology.

[31]  N. Adam,et al.  Late components of the visual evoked potential to search in short-term memory. , 1978, Electroencephalography and clinical neurophysiology.

[32]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[33]  J. Tobin,et al.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.

[34]  E. John,et al.  Evoked-Potential Correlates of Stimulus Uncertainty , 1965, Science.

[35]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[36]  D. Mattingly A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma , 1962, Journal of clinical pathology.

[37]  V. Dole,et al.  Microdetermination of long-chain fatty acids in plasma and tissues. , 1960, The Journal of biological chemistry.

[38]  S. Rapoport,et al.  Glucose transport and metabolism in the brain. , 1986, The American journal of physiology.

[39]  J. H. Zar,et al.  Biostatistical Analysis (5th Edition) , 1984 .

[40]  M. Kutas,et al.  Electrophysiology of cognitive processing. , 1983, Annual review of psychology.